SSRI Antidepressants for Thyroid Patients

When Hormone Therapy Does Not Improve Emotional Symptoms

© Jim Lowrance

Sep 3, 2009
pharmaceuticals, University of Wisconsin-Extension
Patients who have been well-treated for either hypothyroidism or hyperthyroidism may sometimes need the additional help of SSRI antidepressant medications.

Getting thyroid hormones back into balance when the thyroid is overactive or under-active can go a long way toward relieving symptoms of anxiety and/or depression. For some thyroid patients however, emotional symptoms will linger even after adequate or optimal treatment is administered for their thyroid disorder. SSRI antidepressants are often the treatment that is added to address stubborn emotional symptoms.

Emotional Symptoms Associated With Thyroid Autoimmunity

According to medical research published on the PubMed website (U.S. Gov.-National Institutes of Health), anxiety and mood disorders can be directly related to “anti-thyroidperoxidase auto-antibodies” (anti-TPO). These are the antibodies found in most cases of thyroid diseases caused by an immune system response, in which they are sent to attack protein/enzymes in the thyroid gland.

One particular study entitled “The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future”, states that psychiatric disorders in thyroid patients may be rooted in the “thyroid autoimmunity” and not easily correctable. There are a number of other studies with similar conclusions. These type studies demonstrate the fact that correcting thyroid hormone imbalances does not treat or halt the disease process itself and therefore symptoms such as the emotional ones may need additional treatments.

SSRI Antidepressants Can Decrease Thyroid Hormones

SSRI stands for “selective serotonin reuptake inhibitors” and is the most commonly prescribed type of antidepressant, for both anxiety and depression symptoms. Medical research studies have found that SSRI antidepressants can cause a slight decrease in both the T3 and T4 thyroid hormone levels. In one study, this conclusion came after trials of the drug were given to 19 patients with major depression and their blood baseline thyroid hormone levels before the trial were compared to their retested levels following the drug treatment and post-treatment levels were significantly lowered by the drug.

The research study titled “Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors” also mentions the fact that keeping thyroid hormone levels at “optimal” range in patients treated with SSRI drugs can increase the effectiveness of antidepressant treatment. This is mentioned despite the fact that the participants used in the drug trial were not thyroid patients. This would seem to indicate even more importance in treated thyroid patients having optimal thyroid hormone levels to aid in SSRI antidepressant treatment.

Adjusting the Thyroid Hormone Therapy Dose

With the fact that an SSRI drug may decrease a treated hypothyroid patient’s thyroid hormone levels, a treating doctor may want to retest a patient being treated with the drug, to see what hormone dose adjustments might be needed. If a patient has been on thyroid hormone therapy long enough to only require blood retesting of their hormone levels every three to six months, adding an SSRI antidepressant might require that the blood retest scheduling be shortened.

The blood retesting typically used in newly treated hypothyroid patients, which would be about every 8-weeks, might be a good idea until an antidepressant has also fully adjusted in the body. This way the doctor can see if the drug has any lowering affect on thyroid hormone levels, so that they can be raised accordingly. Optimizing treatment for hypothyroidism may lend toward greater success in treating emotional symptoms with SSRI antidepressants.


The copyright of the article SSRI Antidepressants for Thyroid Patients in Thyroid Disorders is owned by Jim Lowrance. Permission to republish SSRI Antidepressants for Thyroid Patients in print or online must be granted by the author in writing.


pharmaceuticals, University of Wisconsin-Extension
       


Post this Article to facebook Add this Article to del.icio.us! Digg this Article furl this Article Add this Article to Reddit Add this Article to Technorati Add this Article to Newsvine Add this Article to Windows Live Add this Article to Yahoo Add this Article to StumbleUpon Add this Article to BlinkLists Add this Article to Spurl Add this Article to Google Add this Article to Ask Add this Article to Squidoo